Shipments of SOZO with L-Dex Commence in the US
Filed with ASX · · 2 pages · English
Watch ImpediMed's latest callImpediMed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of ImpediMed (ASX:IPD) Q1 2027 Earnings CallStory so far
Earlier from ImpediMed
- New Study Reports Superior Clinical Outcomes Utilising L-Dex
- Appendix 4E - year ended 30 June 2017
- Heart Failure 510(k) Application for SOZO Submitted to FDA
- US FDA 510(k) Clearance Issued for SOZO with L-Dex
- First patient enrolled in SOZO CHF Trial at Scripps Health
Later from ImpediMed
- Appendix 4C - Quarter ended 30 September 2017
- Multi-year Exclusive Distribution Agreement Signed
- 2018 Reimbursement Amounts Published by CMS
- L-Dex Abstracts to be Presented at Breast Cancer Symposium
- US FDA 510(k) Clearance Issued for CHF Monitoring with SOZO
Follow ImpediMed into a list and get an email when it puts out news.
Follow ImpediMed